A detailed history of Eam Investors, LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Eam Investors, LLC holds 92,522 shares of ALDX stock, worth $443,180. This represents 0.09% of its overall portfolio holdings.

Number of Shares
92,522
Holding current value
$443,180
% of portfolio
0.09%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.19 - $6.32 $295,145 - $584,739
92,522 New
92,522 $498,000
Q1 2023

Jul 12, 2023

SELL
$5.77 - $9.93 $464,813 - $799,931
-80,557 Reduced 27.59%
211,388 $2.1 Million
Q1 2023

May 12, 2023

BUY
$5.77 - $9.93 $540,747 - $930,609
93,717 Added 47.28%
291,945 $2.9 Million
Q4 2022

Feb 14, 2023

SELL
$5.08 - $7.09 $179,882 - $251,056
-35,410 Reduced 15.16%
198,228 $1.38 Million
Q3 2022

Nov 14, 2022

BUY
$3.8 - $7.74 $887,824 - $1.81 Million
233,638 New
233,638 $1.25 Million
Q3 2021

Nov 12, 2021

SELL
$7.94 - $11.31 $2.61 Million - $3.72 Million
-328,539 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$10.44 - $14.85 $2.35 Million - $3.35 Million
225,348 Added 218.38%
328,539 $3.72 Million
Q1 2021

May 11, 2021

BUY
$6.53 - $14.42 $673,837 - $1.49 Million
103,191 New
103,191 $1.23 Million
Q1 2019

May 13, 2019

SELL
$7.14 - $9.85 $2.21 Million - $3.05 Million
-310,024 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$7.26 - $13.29 $15,013 - $27,483
-2,068 Reduced 0.66%
310,024 $2.57 Million
Q3 2018

Nov 08, 2018

BUY
$6.8 - $14.35 $2.12 Million - $4.48 Million
312,092 New
312,092 $4.31 Million

Others Institutions Holding ALDX

About Aldeyra Therapeutics, Inc.


  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $279M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.